Pharmacodynamics<unk>  is a steroidal antiandrogen, progestin, and antigonadotropin. It has virtually no estrogenic or androgenic activity. Its side-effect profile indicates that it possesses clinically relevant glucocorticoid activity. An active metabolite of<unk> , 15β-hydroxyosaterone<unk> , has potent antiandrogenic activity similarly to<unk> .<unk>  treats BPH in dogs by reducing the actions of androgens in the prostate gland. Pharmacokinetics The major active metabolite of<unk>  is 15β-hydroxyosaterone<unk> .<unk>  has a long biological half-life of 80 hours to 197 ± 109 hours in dogs.
Osaterone acetate
Benzestrol
Anastrozole
Hexestrol
Estradiol dienantate
Dienestrol diacetate
Fosfestrol
Endoxifen